MyData-TRUST
supports Life Sciences Industry to protect patient data and be prepared for data protection regulations
GDPR, General Data Protection Regulation
Voted in May 2016, in force in May 2018
Our Expertise
- A Risk Based approach -
Full coverage of services: consulting, implementation and solutions
Dedicated to Life Sciences with Data Protection expertise
MyData-TRUST
is composed of a multi-disciplinary team
including data privacy lawyers, IT security specialists and life sciences subject matter experts
This unique association of skills and knowledge allows to quickly and efficiently address our clients needs in providing a range of services and solutions aligned with both Pharmaceutical R&D and GDPR requirements.
Contact usManagement Team

Xavier Gobert is a respected and dedicated data professional.
He has a record of more than 20 Years in the Pharmaceutical Industry. He is a passionate clinical data standards expert leading the French Users Group of CDISC since 2011.
He successfully operated in multicultural teams in big pharmaceutical organizations as well as IT and clinical services providers. Xavier has a deep knowledge of EMA and FDA regulations. He is certified in Data Protection.
He has a record of more than 20 Years in the Pharmaceutical Industry. He is a passionate clinical data standards expert leading the French Users Group of CDISC since 2011.
He successfully operated in multicultural teams in big pharmaceutical organizations as well as IT and clinical services providers. Xavier has a deep knowledge of EMA and FDA regulations. He is certified in Data Protection.

Gautier Sobczak is Engineer in Biotechnologies with double expertise in R&D and business development.
He has a strong network and knowledge of the Life Science sector and mainly operated through clinical service providers and biotech companies.
He joined MyData-TRUST as Head of Business Development & Marketing.
Xavier Gobert, CEO
« Data Protection is no longer just a compliance or security issue »
It has become a strategic topic at boardroom level since significant changes to the European legislation were announced.